GET DAILY SIGNALSNature's Sunshine (NATR) Posts Q3 Miss: Sales Fall 9.1%, Guidance Lowered
Key Takeaways
- Q3 2026 net sales declined 9.1% year over year to $116.6 million, missing analyst consensus of roughly $129.5 million.
- Adjusted earnings per share (EPS) of $0.14 fell well short of the $0.25 consensus estimate, while GAAP diluted EPS dropped to $0.11 from $0.30 a year earlier.
- Adjusted EBITDA fell to approximately $11.1 million from $15.2 million in the prior-year quarter.
- Management lowered full-year 2026 guidance to net sales of $460–$470 million and adjusted EBITDA of $44–$48 million, down from its prior ranges.
- The company cited operational disruptions in China, ongoing weakness in Taiwan, and a normalization in its North America digital business as key drivers.
- The balance sheet remains debt-free, with $89.4 million in cash and cash equivalents at quarter-end.
Earnings Context and Why It Matters
Nature's Sunshine Products, Inc. (NATR) is a global manufacturer and distributor of nutritional and personal care products, operating across Asia, Europe, North America, and Latin America. The company entered 2026 with strong momentum, reporting record first-quarter sales and continued expansion of its digital and subscription autoship channels. That backdrop made the third-quarter print especially significant: investors were watching whether the growth engine could be sustained across regions, and whether elevated gross margins and a debt-free balance sheet could be maintained. The quarter matters because it tests the credibility of management's "Vision for Growth" strategy, which targets doubling the business to $1 billion in sales over time. A stumble here raises questions about the durability of recent momentum.
Reported Results
For the third quarter ended September 30, 2026, Nature's Sunshine reported net sales of $116.6 million, down 9.1% from $128.3 million a year earlier and below the consensus estimate of approximately $129.5 million. GAAP diluted EPS came in at $0.11, compared with $0.30 in the prior-year period. On an adjusted basis, EPS of $0.14 missed the $0.25 consensus expectation by a wide margin.
Adjusted EBITDA declined to roughly $11.1 million from $15.2 million in Q3 2025, while operating margin contracted to 4.5% from 7.0% a year ago. Selling, general, and administrative expenses decreased to $42.3 million from $45.7 million, reflecting disciplined cost management amid softer sales. On the balance sheet, the company ended the quarter with $89.4 million in cash and cash equivalents and no debt, and it repurchased 232,000 shares for approximately $3.5 million.
Management pointed to three primary headwinds: continued year-over-year declines in China, where operational disruptions weighed on its consultant leadership base; ongoing weakness in Taiwan; and more normalized comparisons in the North America digital business after several quarters of exceptional growth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Reaction and Investor Sentiment
Investor reaction to the report was sharply negative. Shares of NATR dropped roughly 13.3% to around $11.13 immediately following the release, according to market data, as the revenue miss and reduced full-year outlook overshadowed the company's still-strong balance sheet. The magnitude of the miss, particularly in adjusted EPS and the lowered guidance midpoint, signaled to investors that the challenges in China and the digital business were more persistent than previously communicated.
Sentiment had been building through the first half of 2026 on the back of digital growth and record quarterly sales, but the third-quarter reset reminded the market of the inherent volatility in direct-selling and regionally concentrated revenue. The stock's decline reflects a repricing of near-term growth expectations rather than a reassessment of the company's long-term strategic direction.
Forward Outlook and Key Factors to Monitor
Looking ahead, management now expects full-year 2026 net sales of $460–$470 million and adjusted EBITDA of $44–$48 million, a meaningful reduction from the $490–$500 million and $48–$52 million ranges issued in August. For the fourth quarter, the company anticipates gross margin in the low 72% range, slightly below the prior year due to unfavorable foreign exchange.
Investors should watch several catalysts over the coming quarters. First is China: management has acknowledged that operational disruptions damaged its consultant leadership base, which it has begun rebuilding, but expects challenges there to continue into 2027. Second is the North America digital business, where comparisons are normalizing after several quarters of outsized growth; sustaining customer acquisition and subscription autoship adoption will be critical.
Additionally, the company is preparing several growth initiatives under its "Vision for Growth" plan, including the launch of a women's health product across Asia, a reimagined U.S. direct-selling program expected by mid-2027, expansion in Germany and Japan, and potential entry into another Asian market pending licensing approval. Management has also signaled an openness to mergers and acquisitions to accelerate toward its $1 billion sales goal, though timing remains uncertain. With no debt and a solid cash position, the company retains financial flexibility to execute these plans even as near-term results face pressure. From what I see, monitoring execution on these initiatives will be key.
Using AI Tools in My Research
When evaluating earnings misses like this one, I often rely on Tickeron's AI tools to quickly scan for comparable setups across the health and wellness sector and to review historical pattern performance. It helps me put the numbers in broader context without spending hours on manual analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NATR's RSI Indicator ascends from oversold territory
The RSI Oscillator for NATR moved out of oversold territory on October 22, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In 21 of the 28 cases the stock moved higher. This puts the odds of a move higher at 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where NATR advanced for three days, in 166 of 241 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
NATR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NATR as a result. In 68 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NATR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
The Aroon Indicator for NATR entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.254) is normal, around the industry mean (6.194). P/E Ratio (11.833) is within average values for comparable stocks, (7.022). Projected Growth (PEG Ratio) (1.999) is also within normal values, averaging (8.458). NATR's Dividend Yield (0.331) is considerably higher than the industry average of (0.048). P/S Ratio (0.480) is also within normal values, averaging (5.003).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. NATR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NATR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of nutritional and personal care products
Industry FoodMajorDiversified
Advertisement